Gasto sanitario público y mortalidad por COVID-19 en España y en Europa

OBJECTIVE: To analyze the association between public health expenditure per capita and the mortality rate due to COVID-19 in Europe and Spain. MATERIAL AND METHODS: Pearson's correlation coefficient was used to compare and contrast the mortality rate due to COVID-19 between countries and autono...

Descripción completa

Detalles Bibliográficos
Autores principales: Elola-Somoza, F.J., Bas-Villalobos, M.C., Pérez-Villacastín, J., Macaya-Miguel, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). 2021
Materias:
Original Breve
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710348/
https://www.ncbi.nlm.nih.gov/pubmed/33288965
http://dx.doi.org/10.1016/j.rce.2020.11.003
Descripción
Sumario:OBJECTIVE: To analyze the association between public health expenditure per capita and the mortality rate due to COVID-19 in Europe and Spain. MATERIAL AND METHODS: Pearson's correlation coefficient was used to compare and contrast the mortality rate due to COVID-19 between countries and autonomous communities with higher and lower public health expenditure per capita than the mean. RESULTS: No correlation between the public health expenditure per capita and the mortality rate due to COVID-19 (r: 0.3; p = 0.14) was found among European countries or Spain's Autonomous Communities (r: 0.03; p = 0.91). No significant differences were found when comparing the mortality rate due to COVID-19 among the public health expenditure per capita groups. CONCLUSIONS: The available evidence does not support association between «low» public healthcare expenditure and the poor outcomes observed in Spain during the COVID-19 pandemic. Increased funding for the Spanish National Health System should be earmarked for structural reforms to increase its social efficiency.

Ejemplares similares